The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

NCT03509961 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

95

Enrollment

OTHER

Sponsor class

Conditions

B-cell Acute Lymphoblastic Leukemia

Interventions

DIAGNOSTIC_TEST: NGS-MRD
DRUG: Myeloablative allogeneic HCT with a non-TBI conditioning regimen

Sponsor

Pediatric Transplantation & Cellular Therapy Consortium